Aviva and Socius set to develop the world's leading cancer research district in Sutton

Published:
02 Oct 2023

Last week, councillors unanimously selected Aviva and mixed-use developer Socius as the preferred investment partners to deliver the next phase of the London Cancer Hub. 

Once completed, the large life sciences campus will feature green, vibrant public spaces with a focus on wellbeing, creating an attractive place to work and visit, a healing environment for patients, as well as delivering significant education and economic benefits and new jobs for Sutton residents. 

Councillor Ruth Dombey, Leader of the Council, said: “I’m delighted we have reached this stage in the process and I look forward to completing the deal and seeing the next phase of our ambitions for the London Cancer Hub delivered. The Centre will bring many benefits to Sutton, London and the rest of the UK through the creation of high quality jobs, education opportunities and space for growing businesses. It will also make Sutton home to an internationally recognised centre for the treatment and cure of cancer, discovering new drugs and most importantly, saving lives.” 

Read the full press release on the Aviva website.